Comparison Of 4 CP-690,550 Doses Vs. Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis in Japan

NCT00603512 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: Placebo
DRUG: CP-690,550
DRUG: CP-690,550
DRUG: CP-690,550
DRUG: CP-690,550

Sponsor

Pfizer